Validation pour Ingenuity226

vers la météo de la validation par utilisateur

Ingenuity226

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 23 - PMID ?

In female adult SP , subcutaneous injection of NODE protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 1

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 2

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 3

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 4

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 5

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 6

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 7

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 8

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 9

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 10

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 11

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
                    |                      |                             |                       +------------COMP:N-N(of)------------+        |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 12

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 13

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 14

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +MOD_ATT:N-AD+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 15

                    +-------------------------------------------------------COMP:V-N(In)-------------------------------------------------------+                                   
                    |                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                                   
                    |                      |                             +---------------------OBJ:V-N--------------------+                    |                                   
       +-MOD_ATT:N-N+                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     +MOD_AT+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,injection)
OBJ:V-N (decrease,formation)

Analyse 16

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |                    +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       +------------MOD_ATT:N-N------------+                    |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     +---------MOD_ATT:N-N---------+                    |        |                       +------------COMP:N-N(of)------------+        |                                   
       |     |      +-----MOD_ATT:N-ADJ----+                    |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     |      |           +MOD_ATT:N-+COMP:N-N(of)+       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 17

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
       +------------MOD_ATT:N-N------------+                    +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       |     +---------MOD_ATT:N-N---------+                    |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     |      +-----MOD_ATT:N-ADJ----+                    |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     |      |           +MOD_ATT:N-+COMP:N-N(of)+       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 18

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |                    +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       +------------MOD_ATT:N-N------------+                    |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     +---------MOD_ATT:N-N---------+                    |        |                       +------------COMP:N-N(of)------------+        |                                   
       |     |      +-----MOD_ATT:N-ADJ----+                    |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     |      |           +MOD_ATT:N-+COMP:N-N(of)+       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)

Analyse 19

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
       +------------MOD_ATT:N-N------------+                    +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       |     +---------MOD_ATT:N-N---------+                    |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     |      +-----MOD_ATT:N-ADJ----+                    |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     |      |           +MOD_ATT:N-+COMP:N-N(of)+       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)

Analyse 20

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |            +-------------------------------------COMP:V-N(of)-------------------------------------+                                   
                                           |            |       +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       +------------MOD_ATT:N-N------------+            |       |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     +---------MOD_ATT:N-N---------+            |       |        |                       +------------COMP:N-N(of)------------+        |                                   
       |     |      +-----MOD_ATT:N-ADJ----+            |       |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     |      |           +MOD_ATT:N-+            |       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
COMP:V-N(of) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 21

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |            +-------------------------------------COMP:V-N(of)-------------------------------------+                                   
       +------------MOD_ATT:N-N------------+            |       +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       |     +---------MOD_ATT:N-N---------+            |       |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     |      +-----MOD_ATT:N-ADJ----+            |       |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +----------COMP:V-V(to)---------+   
       |     |      |           +MOD_ATT:N-+            |       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                     |   
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                     |   
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
COMP:V-N(of) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)
COMP:V-V(to) (decrease,bone)

Analyse 22

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |            +-------------------------------------COMP:V-N(of)-------------------------------------+                                   
                                           |            |       +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       +------------MOD_ATT:N-N------------+            |       |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     +---------MOD_ATT:N-N---------+            |       |        |                       +------------COMP:N-N(of)------------+        |                                   
       |     |      +-----MOD_ATT:N-ADJ----+            |       |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     |      |           +MOD_ATT:N-+            |       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
COMP:V-N(of) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)

Analyse 23

                                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                   
                                           |            +-------------------------------------COMP:V-N(of)-------------------------------------+                                   
       +------------MOD_ATT:N-N------------+            |       +-----------------------------------SUBJ:V-N-----------------------------------+                                   
       |     +---------MOD_ATT:N-N---------+            |       |        +---------------------OBJ:V-N--------------------+                    |                                   
       |     |      +-----MOD_ATT:N-ADJ----+            |       |        +--------OBJ:V-N--------+                        +COMP:N-N(of+        |                                   
       |     |      |           +MOD_ATT:N-+            |       |        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        +-OBJ:V-N-+                         
       |     |      |           |          |            |       |        |       |       |       |               |        |       |   |        |         |                         
 In female adult __SP__ , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) decreases formation to trabecular bone .
MOD_ATT:N-N (injection,female)
MOD_ATT:N-N (injection,adult)
MOD_ATT:N-ADJ (injection,__SP__)
MOD_ATT:N-ADJ (injection,subcutaneous)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,injection)
COMP:V-N(of) (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
OBJ:V-N (decrease,formation)